US Air Force Increases Funding for Tandem CIGS Photovoltaics

Ascent Solar Technologies, Inc., a developer of state-of-the-art, thin-film photovoltaic materials, announced today that the US Air Force Research Laboratory (AFRL) has contracted to increase funding of Ascent Solar's development of high-performance thin-film tandem photovoltaics (PV) based on their flexible monolithically integrated CIGS technology. The contract modification represents up to $749,000 of additional contract value over a 27-month period.

Since 1995, AFRL has provided funding for the development of the flexible CIGS at ITN Energy Systems, Inc. and now at Ascent Solar, including the development of aspects of future tandem devices. Tandem solar cells are two solar cells in a stack, where the top cell collects the blue portion of the solar spectrum and the bottom cell collects the rest of the visible spectrum. It is believed that the type of technology pursued by this AFRL program has the potential to reach an efficiency of 20% in the future.

Ascent Solar Chief Technical Officer Dr. Joseph Armstrong stated, "While our baseline CIGS that utilizes a single junction to convert the sun's energy has been performing very well, we are always striving to increase cell performance that can potentially lead to further reductions in system-level costs to the end user. Efficient conversion of the sun's energy is very critical to space and near-space applications, as higher efficiencies correlate directly to smaller, lighter-weight solar arrays, and significantly lower launch cost. Likewise, in terrestrial and building integrated photovoltaic (BIPV) applications, such as roofing tiles and building facades that operate at elevated temperatures, future tandem devices can provide a significant advantage over existing thin film by delivering more power in less area."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.